The extracellular matrix (ECM) consists of proteins, 
Introduction
Stem cells (SCs) are present in all tissue types, giving the origin to different cell lineages or performing tissue repair, among other functions; in this sense, the skeletal muscle is no exception. Muscle regeneration is mainly performed by satellite cells located on the surface of muscle fibers, just under the basal lamina. A satellite cell is frequently considered as a progenitor cell due to its unipotency; however, the engraftment capacity of isolated satellite cells into injured skeletal muscle is rather poor (Asakura et al. 2007 , Mu et al. 2011 whereas cells from other sources, e.g. mesoangioblasts (Sampaloesi et al. 2006) and pericytes (Dellavalle et al. 2007 , Birbrair et al. 2013 engraft into muscle fibers with a greater efficacy. Furthermore, the population of satellite cells is highly heterogeneous, some are derived from dermatomyotomes, others from prechordal mesoderm or several other possible sources. As a result, a minor subpopulation of satellite cells may include myogenic stem cells. For example, on the basis of different adhesive properties of cells Urish et al. (2005) separated a specific satellite cell population that is more resistant to oxidative stress. On the other hand, Tanaka et al. (2009) were able to isolate a rare side population subset of muscle cells characterized by the co-expression of ABCG2, Syndecan4 and Pax7. These cells occupied the satellite cell niche and exhibited a more robust stemness potential than previously Vol. 68 characterized muscle progenitor cells, because these cells were capable of repopulating 75 % of mature myofibers after transplantation (Tanaka et al. 2009 ). The identification of muscle-derived SCs has been complicated because several other cell types exhibit myogenic potential, i.e. interstitial muscle cells, mesenchymal stromal cells, pericytes, mesoangioblasts and hematopoietic SCs (which contribute to muscle regeneration through myelomonocytic precursors). In addition, myogenic cells can be also obtained from non-myogenic tissues, including brain, kidney, lung, thymus, intestine, synovial membrane, etc. (for review see Zammit et al. 2006) .
Tissue injury is known to dysregulate well-balanced factors and feedback control mechanisms of the affected area, not only at homeostasis level but also at organ and system levels, with some events occurring at the level of the entire organism as well. Therefore, the response for tissue injury is complex and involves not only local factors (SCs activation, paracrine signaling, proliferation of adjacent cells, changes in niche structure and tissue vascularization, inflammatory cells infiltration, recruitment of new cells, etc.) but also a systemic response (immune response, cell mobilization, endocrine signaling, stress, changes in metabolism, etc.). However, the extent of these events depends largely on injury degree. A key factor involved in the negative control of skeletal muscle homeostasis and the maintenance of muscle size was identified as a member of the TGF-α family, myostatin. This factor, also known as growth and differentiation factor 8 (GDF8), is secreted from myocytes and negatively regulates the generation of new muscle cells (for review see Bradley et al. 2008) . Moreover, myostatin binds and activates a complex formed by the Acvr2b receptor and ALK4 or ALK5 proteins, which is expressed by muscle SCs and proliferating myoblasts, thus inhibiting the expression of muscle regulatory factors and preventing satellite cell activation, myoblast proliferation and myogenesis. Through an autoregulatory loop, myostatin represses its own transcription and degrades the myostatin/Acvr2b complex. Moreover, myostatin signaling prolongs the survival of muscle fibers via the p53 pathway and stabilizes motor end-plates. The muscle regulatory factors (including MyoD), expressed during myocyte maturation, support myostatin gene transcription; although the bioavailability of the active myostatin homodimer is tightly controlled by multiple factors, e.g. through the expression of its extracellular antagonist, follistatin. The well-orchestrated interplay between developing and maturing cells creates a careful balance of muscle homeostasis that is optimal for muscular function and also allows its rapid regeneration in the case of injury; although it is known that loss-of-function mutations of the GDF8 gene can alter this delicate balance, resulting in a highly increased number and size of myocytes (JouliaEkaza et al. 2006) . 
Extracellular matrix
The components of the extracellular matrix (ECM) include basal laminas, connective tissue fibers, multi-adhesive glycoproteins, and proteoglycans, that play a key role in maintaining the structural integrity of tissues and organs. The ECM allows cell adhesion and regulates cell behavior through binding cell membrane receptors (e.g. integrins), bioactive growth factors, and altering local tissue stiffness (Calve and Simon, 2012) . Therefore, the ECM plays an important role in maintaining the structural features of skeletal muscle. The ECM also provides a framework for the cells, contributes to tissue elasticity, and plays a role in directing the functions of residing cells. Recently, aging has been associated with pathogenic ECM architecture and increased muscle stiffness. These age-related alterations in the ECM induce a pathogenic fibroblast phenotype via YAP-TAZ signaling that directs muscle cell differentiation into a fibrogenic instead of myogenic lineage (Stearns-Reider et al. 2017) , thus suggesting the ECM as a novel therapeutic target in the treatment of muscular degeneration.
The assembly of ECM components in mammalian organs is highly ordered, while currently available artificial scaffolds and constructs can hardly mimic the complexity of biological systems. However, decellularization procedures allow to obtain a biostroma, which retains organ microstructure and original composition of structural and bioactive molecules supporting cell attachment and organization. Although acellular scaffolds are immunologically inert and maintain organ shape and size, they can support cellular regeneration only to a certain extent after the transplantation because of the lack of viable cells; however, scaffolds precoated with living cells have improved integration capacity into the recipient tissues. Recently, several groups have confirmed this concept by the utilization of decellularized bioscaffolds reseeded with cells in the tissue engineering of complex bioartificial organs such as the heart (Ott et al. 2008 ), lung (Petersen et al. 2010 ), or liver (Uygun et al. 2010 , which are fully functional and transplantable.
Skeletal muscles
Skeletal muscles that have been lost due to severe injury could be replaced by autografts during reconstruction surgery; however, the availability of suitable tissue for these autografts is severely limited. This pitfall could be overcome by the construction of artificial muscles created by the colonization of decellularized muscles with suitable cells, which shares much in common with isotransplants of entire muscles (e.g. extensor digitorum muscle) and show an excellent muscle reconstitution after the transplantation in recipients (Čížková et al. 2009a) . Nevertheless, we have previously demonstrated that the basal laminas and satellite cells are left intact in isotransplanted tissues and that they are capable of initiating myogenesis accompanied by vascularization, innervation, and restoration of the muscle sensory reception, including the formation of muscle spindles (Čížková et al. 2009a,b) . Earlier approaches to reconstructive surgery exploited tube-like components of acellular muscle as a scaffold, promoting axonal regrowth after spinal cord hemidissection to bridge a gap in sciatic nerve defects or to fill missing tissue in muscle defects (Arai et al. 2000 , Fansa et al. 2001 . Recently, a preparation of acellular muscle grafts has been optimized (Gillies et al. 2011) , and their reseeding with myoblasts gave rise to engineered muscle constructs with histomorphological characteristics resembling native muscle which, under in vitro conditions, were capable of generating contractile force (Borschel et al. 2004 , Valentin et al. 2010 . Furthermore, we have demonstrated that high doses of whole-body irradiation also induce myeloablation and chimerism in tissues, and the entry of transplanted cells into the small intestine and liver (Filip et al. 2014) . However, other functional characteristics of these grafts reoccupied with myogenic and non-myogenic cells after implantation have yet to be determined in animal models.
Role of intracellular Ca

2+
Ca
2+ is a ubiquitous intracellular messenger controlling a diverse range of cellular processes, such as gene transcription, muscle contraction and cell proliferation. ] i within a cell is finely modulated in terms of ion quantity, time and space, thus constituting a complex language that can only be interpreted by specific proteins (Viero et al. 2014 (Fig. 1) . This is the case of the store-operated Ca 2+ entry, mitochondrial Ca 2+ uptake, and the IP3 cascade. These processes were recently described in skeletal muscle cells. The "storeoperated Ca 2+ entry" allows storage refilling after muscle fiber depolarization, which can also be activated after partial depletion of the SR (Troadec et al. 1998 , Boccara et al. 1999 , Pubill et al. 2001 , Dayanithi et al. 2012 
Skeletal muscle dystrophy and the role of calpain 3
Calpains are a family of Ca 2+ -dependent cysteine proteases (for review see Croall and DeMartino 1991 , Carafoli and Molinari 1998 , Goll et al. 2003 , the members of which are expressed ubiquitously (calpains 1 and 2) or in a tissue-specific way (calpain 3 is skeletal muscle specific and an isoform of calpain 3 was found in the lens). It was shown that in addition to Ca 2+ ions, the activation of calpains is also modulated by the association with a 30 kD small subunit or to membranes, by the autolysis of N-terminus or by an inhibitor (calpastatin). The activation and concentration of the calpains were found to be increased in the mouse model of Duchenne muscular dystrophy (mdx mice). The protein degradation was enhanced in mdx muscle (Turner et al. 1988) , suggesting that increased degradation resulted from the elevated Ca 2+ levels existing within the dystrophic muscle. The known substrates of calpains are the membrane-associated cytoskeletal proteins, the plasma membrane (PM) Ca 2+ -ATPase and the ion channel proteins. Other studies demonstrated that the Ca 2+ pump located in the PM is a preferred substrate of calpain in erythrocytes (Salamino et al. 1994) . It has also been shown that the calpains in normal tissues exert regulatory roles including in dystrophic process by affecting the metabolic pathway and cleave substrates at restricted locations (Carafoli and Molinari 1998) . This evidence supports the important role for pathologically high calpain activity in muscular dystrophy through disruption of specific regulatory mechanisms in muscles. In earlier studies using primary culture of mouse skeletal muscle from calpain 3-deficient (capn3 -/-) mice (which are fully fertile and viable, and showed a mild muscular dystrophy that affects a specific group of muscles) it was shown that affected muscles manifest a similar apoptosis-associated perturbation of the IκBα/NFκB pathway as seen in
LGMD2A patients (Baghdiguian et al. 1999 ) and capn3 -/-mice .
Calpain 3 knock-out mice as a model to study the muscle dystrophy and role of [Ca
2+ ] i
Using the primary cultures of skeletal muscle cells from normal and capn3 -/-mice it was demonstrated the upstream and downstream events occurring during pharmacologically-induced [Ca 2+ ] i rise in myoblasts and myotubes from normal and capn3 -/-mice (Dayanithi et al. 2009 ). Here, calpain 3 acts as a feedback regulator for Ca 2+ homeostasis in skeletal muscle cells by exerting its action on RyR. The latter, also known as Ca 2+ release channel, is a key protein involved in excitationcontraction coupling. Its activity is regulated by a 94 kDa thiol-protease of the junctional SR membranes which specifically cleaves one site on the RyR. This cleavage results in enhancement of Ca 2+ efflux from SR vesicles (Shoshan-Barmatz et al. 1994 , Schevchenko et al. 1998 ).
Role of intracellular Ca 2+ stores in muscle dystrophy
Muscular dystrophies represent a heterogeneous group of severe degenerative disorders characterized by progressive muscle fiber weakness, degeneration, and Vol. 68 death. These changes derive from genetic mutations affecting either membrane, cytoplasmic, nuclear or ECM proteins essential for muscle function, therefore turning them into a clinically, genetically and biochemically heterogeneous group. Past and current research into the mechanisms and therapeutic approaches for muscular dystrophies have extensively been developed, encompassing a wide range of strategies such as cellular and stem cell therapies, gene engineering, and various pharmacological approaches.
Of interest, calpains are not completely responsible for this RyR cleavage in both normal and calpain 3-deficient skeletal muscles. The cleavage of RyR in the absence of calpain 3 could be due to calpain 1 and/or 2 which are widely expressed in all cell types. The activity of these calpains could be redundant in that case (Dayanithi et al. 2009 ). To assess the activity of ryanodine-sensitive internal Ca 2+ stores, caffeine stimulation was used to activate RyR (Wang et al. 2003) . The effectiveness of caffeine in normal myotubes in comparison to myoblasts indicated a maturation of a proper RyR signaling in culture during the fusion process. These results indicated that both myoblasts and myotubes from capn3 -/-mice displayed weaker amplitudes of the caffeine-induced [Ca 2+ ] i transients than in normal cells, which could indicate a lower SR Ca 2+ loading state in capn3 -/-skeletal cells, a decreased number of RyR at the SR membrane surface, or a decreased sensitivity of these receptors, but these alterations are independent of any cleavage by calpain 3 (Dayanithi et al. 2009 ). In the above study, cyclopiazonic acid (CPA), a compound that depletes internal Ca 2+ stores (Dayanithi et al. 2009) 
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